TECH
Income statement / Annual
Last year (2025), Bio-Techne Corporation's total revenue was $1.22 B,
an increase of 5.23% from the previous year.
In 2025, Bio-Techne Corporation's net income was $73.40 M.
See Bio-Techne Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
06/30/2025 |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
| Operating Revenue |
$1.22 B |
$1.16 B |
$1.14 B |
$1.11 B |
$931.03 M |
$738.69 M |
$714.01 M |
$642.99 M |
$563.00 M |
$499.02 M |
| Cost of Revenue |
$429.36 M
|
$389.34 M
|
$366.89 M
|
$349.10 M
|
$298.18 M
|
$255.50 M
|
$240.52 M
|
$210.85 M
|
$188.46 M
|
$162.36 M
|
| Gross Profit |
$790.27 M
|
$769.73 M
|
$769.82 M
|
$756.50 M
|
$632.85 M
|
$483.19 M
|
$473.49 M
|
$432.14 M
|
$374.54 M
|
$336.66 M
|
| Gross Profit Ratio |
0.65
|
0.66
|
0.68
|
0.68
|
0.68
|
0.65
|
0.66
|
0.67
|
0.67
|
0.67
|
| Research and Development Expenses |
$99.50 M
|
$96.66 M
|
$92.49 M
|
$87.14 M
|
$70.60 M
|
$65.19 M
|
$62.41 M
|
$55.33 M
|
$53.51 M
|
$45.19 M
|
| General & Administrative Expenses |
$415.10 M
|
$393.32 M
|
$352.44 M
|
$339.00 M
|
$289.92 M
|
$240.88 M
|
$236.87 M
|
$240.64 M
|
$153.33 M
|
$140.88 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$27.49 M
|
$0.00
|
$45.92 M
|
$0.00
|
| Selling, General & Administrative Expenses |
$415.10 M
|
$393.32 M
|
$352.44 M
|
$339.00 M
|
$289.92 M
|
$240.88 M
|
$264.36 M
|
$240.64 M
|
$199.24 M
|
$140.88 M
|
| Other Expenses |
$173.42 M
|
$73.06 M
|
$25.94 M
|
$33.77 M
|
$35.03 M
|
$19.70 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$688.02 M
|
$563.04 M
|
$470.87 M
|
$459.91 M
|
$395.55 M
|
$325.78 M
|
$326.77 M
|
$295.97 M
|
$252.76 M
|
$186.07 M
|
| Cost And Expenses |
$1.12 B
|
$952.37 M
|
$837.76 M
|
$809.01 M
|
$693.74 M
|
$581.27 M
|
$567.29 M
|
$506.82 M
|
$441.22 M
|
$348.43 M
|
| Interest Income |
$3.89 M
|
$3.32 M
|
$3.41 M
|
$794.00 K
|
$473.00 K
|
$605.00 K
|
$569.00 K
|
$409.00 K
|
$304.00 K
|
$249.00 K
|
| Interest Expense |
$8.51 M
|
$15.74 M
|
$11.22 M
|
$11.31 M
|
$13.95 M
|
$19.20 M
|
$21.71 M
|
$10.19 M
|
$7.36 M
|
$1.75 M
|
| Depreciation & Amortization |
$109.90 M
|
$111.71 M
|
$107.24 M
|
$101.07 M
|
$87.75 M
|
$82.74 M
|
$78.17 M
|
$64.46 M
|
$60.04 M
|
$42.76 M
|
| EBITDA |
$216.88 M |
$313.14 M |
$457.11 M |
$413.76 M |
$249.87 M |
$378.41 M |
$211.89 M |
$200.60 M |
$179.36 M |
$191.99 M |
| EBITDA Ratio |
0.18
|
0.27
|
0.4
|
0.37
|
0.27
|
0.51
|
0.3
|
0.31
|
0.32
|
0.38
|
| Operating Income Ratio |
0.08
|
0.18
|
0.26
|
0.27
|
0.25
|
0.21
|
0.18
|
0.21
|
0.22
|
0.3
|
| Total Other Income/Expenses Net |
-$3.79 M
|
-$21.00 M
|
$39.72 M
|
$4.80 M
|
-$89.12 M
|
$119.06 M
|
-$34.70 M
|
-$10.23 M
|
-$8.62 M
|
-$3.11 M
|
| Income Before Tax |
$98.46 M
|
$185.69 M
|
$338.66 M
|
$301.39 M
|
$148.18 M
|
$276.48 M
|
$112.02 M
|
$125.95 M
|
$113.16 M
|
$147.48 M
|
| Income Before Tax Ratio |
0.08
|
0.16
|
0.3
|
0.27
|
0.16
|
0.37
|
0.16
|
0.2
|
0.2
|
0.3
|
| Income Tax Expense |
$25.06 M
|
$17.58 M
|
$53.22 M
|
$38.29 M
|
$8.59 M
|
$47.18 M
|
$15.94 M
|
-$602.00 K
|
$35.88 M
|
$43.01 M
|
| Net Income |
$73.40 M
|
$168.11 M
|
$285.26 M
|
$272.05 M
|
$140.41 M
|
$229.30 M
|
$96.07 M
|
$125.35 M
|
$77.29 M
|
$104.48 M
|
| Net Income Ratio |
0.06
|
0.15
|
0.25
|
0.25
|
0.15
|
0.31
|
0.13
|
0.19
|
0.14
|
0.21
|
| EPS |
0.47 |
1.07 |
1.81 |
1.73 |
0.91 |
1.5 |
0.64 |
0.84 |
0.52 |
0.7 |
| EPS Diluted |
0.46 |
1.05 |
1.76 |
1.66 |
0.87 |
1.45 |
0.62 |
0.82 |
0.52 |
0.7 |
| Weighted Average Shares Out |
$157.52 M
|
$157.71 M
|
$157.18 M
|
$156.88 M
|
$154.99 M
|
$152.80 M
|
$151.12 M
|
$149.90 M
|
$149.25 M
|
$148.78 M
|
| Weighted Average Shares Out Diluted |
$159.72 M
|
$160.77 M
|
$161.86 M
|
$164.12 M
|
$161.93 M
|
$157.60 M
|
$155.57 M
|
$152.22 M
|
$150.00 M
|
$149.30 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
